Cochrane Abstracts
Selective serotonin reuptake inhibitors for fibromyalgia syndrome
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Selective Serotonin Reuptake Inhibitors for Fibromyalgia Syndrome." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/440250/all/Selective_serotonin_reuptake_inhibitors_for_fibromyalgia_syndrome.
Selective serotonin reuptake inhibitors for fibromyalgia syndrome. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440250/all/Selective_serotonin_reuptake_inhibitors_for_fibromyalgia_syndrome. Accessed April 21, 2025.
Selective serotonin reuptake inhibitors for fibromyalgia syndrome. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440250/all/Selective_serotonin_reuptake_inhibitors_for_fibromyalgia_syndrome
Selective Serotonin Reuptake Inhibitors for Fibromyalgia Syndrome [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 April 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/440250/all/Selective_serotonin_reuptake_inhibitors_for_fibromyalgia_syndrome.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Selective serotonin reuptake inhibitors for fibromyalgia syndrome
ID - 440250
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/440250/all/Selective_serotonin_reuptake_inhibitors_for_fibromyalgia_syndrome
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
